Description
We are recruiting a research technician who wants to contribute to
cutting-edge biomedical research in a highly ambitious, collaborative, and
international environment. Our lab is based at the CeMM Research Center for
Molecular Medicine of the Austrian Academy of Sciences in Vienna , on the
campus of one of the world's largest hospitals.
At CeMM, we take career development of our staff seriously. For example, we
will train the successful candidate in state-of-the-art technologies that
are in high demand in academia, industry, and the medical sector. We encourage
contribution to and co-authorship of scientific publications. Importantly,
genomic medicine is a hot topic in Austria and internationally, creating a
highly promising area for a career in biomedical research and
applications.
Your Profile
Bachelor's or master's degree (or equivalent) with strong wet-lab
experience
High accuracy, reliability, precision under time pressure, and
organizational skills
Very strong motivation and commitment, proactive mindset, getting-things-
done attitude
Prior experience working with molecular biology techniques including cell
culture and DNA/RNA assays
Friendly, collaborative mindset and ability to work well in an
international environment
Written and oral communication skills in English (German language skills
are not required)
Motivation to work in one of the fastest-moving and most future-oriented
areas of biomedicine
Your Tasks
High-throughput profiling of patient samples, including next generation
sequencing, single-cell technologies, and CRISPR screens
Cell culture and cell-based assays including the cultivation of patient-
derived organoids and immune cells
Optimization and testing of new assays and protocols, e.g. for cancer
epigenetics, tumor immunology, and stem cell biology
Contribution to lab management, training of new lab members, and
scientific publications
The Bock Lab (https:// epigenomics.cemm.oeaw.ac.at/;
https: // twitter.com/BockLab)
The Medical Epigenomics Lab at CeMM seeks to advance precision medicine
through collaborative, technology-driven biomedical research, developing wet-
lab and computational methods and investigating the epigenetic
(de)regulation underlying cancer and immunity.
Single-cell genomics. Many diseases show deregulation of epigenetic cell
states. As members of the Human Cell Atlas, we use single-cell sequencing
and human organoids to dissect the gene-regulatory foundations of cancer &
immunity.
Computational biology. Bioinformatic methods are essential for advancing
biomedical research. We develop algorithms and software for large-scale
data analysis, and we pursue clinical collaborations to demonstrate health
impact.
High-throughput technology. Many groundbreaking discoveries are driven
by new technologies. We invest heavily into technology development,
including single-cell sequencing, CRISPR screens, epigenome editing, and
synthetic biology.
Machine learning. Huge datasets pose new analytical challenges. As
members of the European Laboratory for Learning and Intelligent Systems,
we develop methods for interpretable deep learning and artificial
intelligence in biology.
Immune cell engineering. CAR T cells have shown dramatic efficacy for
blood cancers and may spearhead a broad shift toward personalized, cell-
based therapies. We use high-throughput technology to design synthetic
immune cells.
Christoph Bock is a Principal Investigator at the CeMM Research Center for
Molecular Medicine of the Austrian Academy of Sciences and Professor of
BioMedical Informatics at the Medical University of Vienna. He is also the
scientific coordinator of the Biomedical Sequencing Facility at CeMM and co-
founder of a Vienna-based start-up company (Myllia Biotechnology). He has
received major research awards, including an ERC Starting Grant (2016-2021),
an ERC Consolidator Grant (2021-2026), the Otto Hahn Medal of the Max Planck
Society (2009), the Overton Prize of the International Society for
Computational Biology (2017), and the Erwin Schrödinger Prize of the
Austrian Academy of Sciences (2022).
The Institute (https:// www. cemm.at)
CeMM is one of Europe's leading biomedical research institutes. CeMM
researchers routinely publish important discoveries in top journals. Over the
last seven years, this included >10 papers in Nature/Cell/Science/NEJM and >30
papers in Nature/Cell sister journals – with a team of 120-150 scientists.
Research at CeMM is exceptionally collaborative and has strong focus on
medical impact, based on a profound molecular understanding of diseases such
as cancer and immune disorders. CeMM is part of the Austrian Academy of
Sciences and a founding member of EU-LIFE. It is located at the center of one
of the largest medical campuses in Europe, within walking distance of Vienna's
historical city center. A study by “The Scientist” put CeMM among the top-5
best places to work in academia worldwide (https: // www. the-
scientist.com/features/best-places-to-work-academia-2012-40676). Vienna is
frequently ranked the world's best city to live. It is a United Nations city
with a large English-speaking community. The official language at CeMM is
English, and >45 different nationalities are represented at the institute.
CeMM promotes equal opportunity and harbors a mix of different talents,
backgrounds, competences, and interests.
We offer
Work within an experienced, interdisciplinary, and international team at
one of Austria's leading research institutes
Ample opportunities to contribute and gain experience in a key area of
biomedical research and precision medicine
An inspiring workplace with an international setting, strong team spirit,
and an excellent work climate
A wide range of social, cultural, and sports activities organized by the
institute
Excellent employee benefits including full insurance coverage (health,
accident, retirement), health care services, subsidized cafeteria
Starting annual gross salary of at least EUR 35,000 (the salary will
reflect the successful candidate's qualifications and can be higher)
Flexible start date. Open-ended full-time contact available after an
initial trial period. Support for relocating to Vienna is provided
Please apply online (https: // cemm.jobbase.io/job/tdtew99q) with cover
letter, CV, academic transcripts, and contact details of 3 referees.
Applications will be reviewed on a rolling basis. Any application received by
22 July 2022 will be considered.
Additional information
City Vienna
Position type Full-time employee
Start of work 01.08.2022
Responsible
Memo Mokhles
